Monitoring Vital Signs in Idiopathic Pulmonary Fibrosis
Part of Lungs & breathing clinical trials.
This study monitors your vital signs before and after a sudden worsening (flare-up) of IPF. It uses a wearable device (Bora Band®) to track your health and help doctors better understand and manage these events.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have Idiopathic Pulmonary Fibrosis (IPF) and have had a lung function test or blood gas test in the last 3 months.
- You have been stable for the past 3 months (no hospital stays or flare-ups).
- Your oxygen level drops below 88% during a 6-minute walk test (you need oxygen when walking but not all the time).
- You are NOT already using oxygen when walking or all the time.
- You can use the Bora Band® device or have a caregiver to help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with idiopathic pulmonary fibrosis (IPF) who are currently having a sudden worsening of breathing symptoms. It may help doctors better understand what happens during these flare-ups and how to manage them.
This study looks at how well people with IPF can exercise and how strong their breathing muscles are. It helps doctors understand the effects of IPF on daily activity.
This study looks at whether routine blood test results can help doctors understand and manage sudden flare-ups of idiopathic pulmonary fibrosis (IPF), a lung disease. If you are admitted to the hospital with a sudden worsening, your blood tests may provide important clues.
This study is looking at people with Idiopathic Pulmonary Fibrosis (IPF), a type of lung scarring. Researchers will use medical records to see if they can better predict how the disease will progress over time.
This trial tests a remote monitoring system (BoraCare®) for people with COPD. It uses a wearable device and an early warning score to detect flare-ups early, so you can get faster care and avoid hospital stays.
This study measures how hard you breathe using a gentle nasal pressure device in people with idiopathic pulmonary fibrosis (IPF). It may help doctors better understand breathing mechanics in IPF and guide future care.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.